The cause of the ongoing massive pandemic, the SARS-CoV-2 virus, originated in Wuhan, China and spread rapidly worldwide. The pandemic has helped identify the difficulties associated with devising best practices necessary to augment the immune system to prevent the contraction of viral infections, as well as enhance the process of recovery if an infection does occur. Medical scholars and researchers have been actively assessing dietary aspects that may improve the health of immune systems. It is already well-established that malnourishment can lead to increased oxidative stress and cause inflammation. Such conditions weaken the immune system and make people vulnerable to bacterial and infectious illnesses. In the current scenario, scientists have confirmed that some dietary components can enhance immunity in COVID-19 patients. Empirical evidence suggested that the condition of COVID-19 patients is largely attributable to increased metabolic rates that drain the body's glucose supplies. This highlights the necessity of improving the quality of enteral nutrition provided to COVID-19 patients. Despite being dietarily sensitive, these individuals require regular monitoring and assessments to discern their nutritional deficiencies. In general, the diet should include foodstuffs with anti-inflammatory properties and micronutrients, including polyphenols, carotenoids, vitamin C, vitamin E, etc. Considering nutrition in the overall treatment provided will greatly fortify the immunity of COVID-19 patients and increase the probability of survival.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3923/pjbs.2022.106.111 | DOI Listing |
Viruses
December 2024
Department of Medical Oncology, Medical University of Sofia, University Hospital "Tsaritsa Yoanna", 1527 Sofia, Bulgaria.
Central nervous system (CNS) infections caused by SARS-CoV-2 are uncommon. This case report describes the clinical progression of a 92-year-old female who developed a persistent neuroinfection associated with SARS-CoV-2. The patient initially presented with progressive fatigue, catarrhal symptoms, and a fever (38.
View Article and Find Full Text PDFViruses
December 2024
I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Background/objectives: The efficacy of monovalent BNT162b2 Omicron XBB.1.5 booster vaccination in liver transplant recipients (LTRs) has yet to be described, particularly regarding the immune response to emerging variants like JN.
View Article and Find Full Text PDFViruses
December 2024
Infectious Diseases Laboratory, Centro de Investigación en Ciencias de la Salud y Biomedicina, Universidad Autónoma de San Luis Potosí, San Luis Potosi 78210, Mexico.
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in young children. During the COVID-19 pandemic, a significant change in the epidemiology of RSV and other viruses occurred worldwide, leading to a reduction in the circulation of these infectious agents. After the pandemic, the resurgence of seasonal respiratory viruses occurred, but some features of these infections contrast to those registered prior to the pandemic.
View Article and Find Full Text PDFViruses
December 2024
1st Department of Critical Care and Pulmonary Medicine, School of Medicine, National and Kapodistrian University of Athens, "Evangelismos" General Hospital, 10676 Athens, Greece.
Hypercoagulation is central to the pathogenesis of acute and post-acute COVID-19. This prospective observational study explored whether rotational thromboelastometry (ROTEM), a method that unveils coagulation status, predicts outcomes of hospitalized patients with COVID-19 pneumonia. We investigated 62 patients using ROTEM that was conducted at enrollment, clinical deterioration, discharge and follow-up visits 1 and 3 months post-discharge.
View Article and Find Full Text PDFViruses
December 2024
Department of Infectious Diseases and Hepatology, Collegium Medicum, Bydgoszcz, Nicolaus Copernicus University, 87-100 Torun, Poland.
Objectives Of The Study: The aim of this study was to assess the impact of the COVID-19 pandemic on the epidemiology and clinical course of chickenpox in children based on 6 years of self-reported observations.
Material And Methods: The medical records of 350 patients under 18 years of age hospitalised in the Department of Paediatrics, Infectious Diseases, and Hepatology between 1 January 2018 to 31 December 2023 were analysed retrospectively.
Results: During the analysed period, 350 children were hospitalised due to chickenpox, the fewest in the pandemic period, the greatest number in 2023.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!